An AI tool based on a new concept called “meta-synergy” helps find more powerful drug combinations.
Israel's Sheba Medical Center initiated and is funding a program to transport Afghan children with the disease into Pakistan for treatment.
The patient with malignant lung cancer suffered from a rare complication in which the tumor secretes a protein that causes acute hypoglycemia. Israeli doctors used a breast cancer drug to treat it.
Ayan Barbora, who led the research, said nanotechnology has a significant role in developing a more-effective therapy for cancer.
In mouse model study, Weizmann Institute scientists test biomarker that could help doctors select lung cancer patients for treatment with a single antibody-based drug.
The drug in question, dubbed AOH1996, works by targeting the protein that helps facilitate cancer cells reproduce and spread throughout the body.
The researchers developed lipid-based nanoparticles – like those used in the COVID-19 vaccine – containing RNA molecules that silence the gene CKAP5.
The sugar was named after food from heaven that nourished ancient Israelis during their wandering in the desert.
The pilot project will continue with another flight for a young cancer patient from Israel’s southern Negev region in the coming weeks.
JPOST Digital Library
